Celltrion signs US$126.2m contract with its affiliate for antibody similar

16:13
S. Korea not to attend Sado mine memorial: foreign ministry
16:01
Gyeongju blends old with new
16:01
[What to Play] Cozy songs to warm you up
16:01
[Weekender] Korea's traditional sauce culture gains global recognition
16:01
Toxins at 622 times legal limit found in kids' clothes from Chinese platforms
16:01
At Gwangcheonok, try North Korean-style sundae gukbap
16:01
Over 80,000 malicious calls made to Seoul call center since 2020
12:52
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
11:45
BLACKPINK's Rose stays at No. 3 on British Official Singles chart with 'APT.'
21:05
What you need to know about Adani's US bribery indictment

Celltrion signs US$126.2m contract with its affiliate for antibody similar

June 22, 2016 - 14:06 By 황유미

[DISCLOSURE] Celltrion (068270) has signed a 145.6 billion won (US$126.2 million) contract with its affiliate Celltrion Healthcare to supply antibody biosimilar, it announced on June 22.

황유미